Biochemical alterations of resveratrol on oxidative stress in experimental induced non - alcoholic fatty liver disease in rats

HEPATOPROTECTIVE EFFECTS OF CHITOSAN AND CHITOSAN NANOPARTICLES

Non alcoholic fatty liver disease: pathogenesis, role of (TNF-α, IL-6) in hepatic inflammation and future potential nutraceutical treatment

Non-Alcoholic Fatty Liver Disease

Hypolipidemic and anti-inflammatory effect of chitosan in experimental induced non -alcoholic fatty liver disease in rats

IRISIN: A POTENTIAL PROMISING AGENT AGAINST NON-ALCOHOLIC FATTY LIVER DISEASE IN TYPE 2 DIABETIC RATS

Non-alcoholic fatty liver disease: Insights into pathogenesis, molecular mechanisms, and therapy

Nonalcoholic Fatty Liver Disease (NAFLD)

Nanoparticle zinc oxide obviates oxidative stress of liver cells in induced-diabetes mellitus model

THE EFFECT OF MELATONIN, METFORMIN AND URSODEOXYCHOLIC ACID ON NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED, DOUBLE-BLINDED CONTROLLED TRIAL